IRVINE, Calif.--(BUSINESS WIRE)-- Allergan, Inc. (NYSE: AGN) ("Allergan" or the "Company") announced today that it has asked the United States District Court for the Central District of California to ...

Allergan's attempt to thwart Bill Ackman and Valeant Pharmaceuticals' $53 billion takeover offer was dealt a blow by California courts this past week. Allergan had hoped its insider trading lawsuit ...

Judge David Carter opted against moving up Allergan's suit against Valeant and Pershing Square, potentially clearing the way for a special meeting that could replace members of Allegan's board by year ...

Allergan 's attempt to thwart Bill Ackman and Valeant Pharmaceuticals ' $53 billion takeover offer was dealt a blow by California courts this past week. Allergan had hoped its insider trading lawsuit ...

The companies will investigate alternate approaches to complement or improve upon existing therapies.Pharmacopeia (Nasdaq: PCOP), a developer of small therapeutics, has entered into an agreement with ...

(Reuters) - The federal judge in California overseeing Allergan Inc's insider trading lawsuit against Valeant Pharmaceuticals and activist investor William Ackman has set an Aug. 20 hearing date to ...

California Attorney General Xavier Becerra sent a letter to the acting secretary of the Federal Trade Commission arguing the agency didn’t follow “best practices” when it approved AbbVie’s $63 billion ...

California Attorney General Xavier Becerra sent a letter to the acting secretary of the Federal Trade Commission arguing the agency didn't follow "best practices" when it approved AbbVie's $63 billion ...

Most of the 1,500 job cuts that Botox maker Allergan Inc. announced Monday morning will be made in Southern California, the company’s chief executive said. Allergan plans to eliminate 650 research and ...